Clinical Trials · NCT00380406

PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Ottawa Hospital Research Institute
Enrollment
30
Start date
Jan 2007
Locations
4 sites, Canada
Primary endpoint
Protection against ovarian failure
View Gonadorelin compound reference